Cohn J R, Jungkind D L, Baker J S
Antimicrob Agents Chemother. 1980 Dec;18(6):872-6. doi: 10.1128/AAC.18.6.872.
Ten strains each of Staphylococcus aureus, Haemophilus influenzae, Enterobacter spp., Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Streptococcus pneumoniae were tested in vitro against erythromycin combined with ampicillin, cefamandole, or gentamicin. Antagonism by erythromycin occurred with 47% of the combinations involving strains of S. aureus and to a lesser degree with H. influenzae. Synergy occurred most commonly with H. influenzae (27%). The high frequency of antagonism and synergy with these organisms was associated with a broad range of bacteriostatic action by erythromycin against these same bacteria. The implications for the treatment of pneumonia are discussed.
对金黄色葡萄球菌、流感嗜血杆菌、肠杆菌属、大肠埃希菌、肺炎克雷伯菌、奇异变形杆菌、铜绿假单胞菌和肺炎链球菌各10株菌株进行了体外试验,以检测红霉素与氨苄西林、头孢孟多或庆大霉素联合使用的效果。红霉素与47%涉及金黄色葡萄球菌菌株的组合产生拮抗作用,对流感嗜血杆菌的拮抗作用程度较小。协同作用最常见于流感嗜血杆菌(27%)。红霉素对这些细菌具有广泛的抑菌作用,因此与这些微生物产生拮抗和协同作用的频率较高。文中讨论了其对肺炎治疗的意义。